Please Wait
| Date | 3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | 3/31/2020 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable Net Current | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Property Plant and Equipement | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Assets | $256,870,892.00 | $288,976,828.00 | $262,956,993.00 | $291,096,643.00 | $284,412,858.00 | $298,861,844.00 | $462,315,827.00 | -- | -- |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accrued Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $75,149,757.00 | $77,005,785.00 | $76,264,269.00 | $76,053,574.00 | $74,392,156.00 | $77,078,233.00 | $97,469,203.00 | -- | -- |
| Long Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Deficit | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities and Equity | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Date | 3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | 3/31/2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and Development | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $4,750,993.00 | $14,832,577.00 | $5,177,558.00 | $5,520,847.00 | $18,164,201.00 | $4,328,744.00 | -- | $8,190,884.00 | $3,256,316.00 |
| Loss from Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss Before Income Taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings Per Share Basic | $-0.87 | $0.53 | $-0.41 | $0.16 | $-0.44 | $-3.92 | -- | $6.39 | $-1.36 |
| Weighted Average Shares Basic | 25,393,490 | 26,549,672 | 27,158,786 | 28,378,529 | 30,023,202 | 29,781,801 | -- | 24,506,181 | 17,440,994 |
| Earnings Per Share Diluted | $-0.87 | $0.53 | $-0.60 | $0.16 | $-4.40 | $-3.92 | -- | $0.55 | $-1.36 |
| Weighted Average Shares Diluted | 25,393,490 | 26,549,672 | 25,952,447 | 28,378,529 | 30,023,202 | 30,542,611 | -- | 25,705,099 | 17,440,994 |
| Common Stock Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | -- | -- |
| Common Stock Shares Outstanding | 25,353,284 | 25,209,108 | 25,398,640 | 28,338,580 | 28,429,499 | 28,333,661 | 31,118,556 | -- | -- |
| Common Stock Value | $253,533.00 | $252,091.00 | $253,986.00 | $283,386.00 | $284,295.00 | $283,337.00 | $311,185.00 | -- | -- |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | -- | -- |
| Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Authorized | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Share Price | -- | -- | -- | $0.10 | -- | -- | -- | -- | -- |